RNS Number : 3759U
MyHealthChecked PLC
28 June 2024
 

 

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

 

Result of AGM

 

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that at the Annual General Meeting ('AGM') of the Company held earlier today, all resolutions put to the Company's shareholders were duly passed.

 

Resolution

(*indicates special resolution)

Votes for

% of shares voted

Votes against

% of shares voted

Resolution 1

8,464,640

99.6%

31,692

0.4%

Resolution 2

8,421,681

99.5%

44,241

0.5%

Resolution 3

8,425,848

99.2%

68,588

0.8%

Resolution 4

8,448,906

99.5%

45,530

0.5%

Resolution 5

1,620,012

95.2%

81,563

4.8%

Resolution 6*

1,361,538

80.0%

340,267

20.0%

Resolution 7*

8,451,080

99.5%

46,232

0.5%

 

Notes:

The full text of, inter alia, the resolutions proposed and passed at the AGM can be found in the Company's Notice of Annual General Meeting which was published and posted to Shareholders on 4 June 2024 and is available on the Company's website at https://investors.myhealthchecked.com/.

 

For further information contact:

 

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR



SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin / Jade Bayat




Dowgate Capital Limited (Broker)

Tel: +44 (0)20 3903 7715

David Poutney / Nicholas Chambers




Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com)

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

 

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. 

 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGQKFBPCBKKDAB
Myhealthchecked (LSE:MHC)
過去 株価チャート
から 10 2024 まで 11 2024 Myhealthcheckedのチャートをもっと見るにはこちらをクリック
Myhealthchecked (LSE:MHC)
過去 株価チャート
から 11 2023 まで 11 2024 Myhealthcheckedのチャートをもっと見るにはこちらをクリック